Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Aug;53(2):272-80.

Cell-mediated immune response to respiratory syncytial virus infection in owl monkeys

Cell-mediated immune response to respiratory syncytial virus infection in owl monkeys

W C Koff et al. Clin Exp Immunol. 1983 Aug.

Abstract

The suitability of owl monkeys as experimental models to study the cellular immune response to respiratory syncytial virus (RSV) infection was examined. Seronegative owl monkeys inoculated intranasally with RSV shed large quantities of virus and developed clinically evident upper respiratory disease. RSV infected monkeys had significant lymphoproliferative responses to RSV antigen by 4 weeks post-infection. In contrast, no positive blastogenic responses were elicited during the acute phase of illness. An in vitro 51Cr release assay was developed to study owl monkey antibody-dependent cellular cytoxicity (ADCC) against RSV infected Hep-2 cells. Peripheral blood mononuclear cells from owl monkeys in the presence of RSV specific antibody caused lysis of RSV infected target cells. The effector cell for ADCC was found to be non-adherent to plastic. The owl monkey RSV ADCC system was found to closely parallel RSV specific ADCC observed with human effector cells. In addition, it was found that heterologous matches of human effector cells with monkey sera and monkey effector cells with human sera were equally efficient in mediating RSV specific ADCC. These studies demonstrate the value of the owl monkey as a model to study the pathogenesis or RSV infections.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Infect Immun. 1979 Nov;26(2):764-6 - PubMed
    1. Prog Med Virol. 1980;26:94-118 - PubMed
    1. J Immunogenet. 1981 Dec;8(6):433-42 - PubMed
    1. Lancet. 1963 Feb 9;1(7276):295-8 - PubMed
    1. Pediatrics. 1965 Jul;36:21-39 - PubMed

MeSH terms

Substances

LinkOut - more resources